India's government has revoked the patent on Roche's (RHHBY.OB) expensive Pegasys drug for...

|About: Roche Holding Ltd ADR (RHHBY)|By:, SA News Editor

India's government has revoked the patent on Roche's (RHHBY.OB) expensive Pegasys drug for hepatitis C, part of a series of revocations for multinational drug companies' expensive treatments in the country. India's drug market is expected to grow to $74B in 2020 from $11B last year.